FR2154739A1 - - Google Patents

Info

Publication number
FR2154739A1
FR2154739A1 FR7234605A FR7234605A FR2154739A1 FR 2154739 A1 FR2154739 A1 FR 2154739A1 FR 7234605 A FR7234605 A FR 7234605A FR 7234605 A FR7234605 A FR 7234605A FR 2154739 A1 FR2154739 A1 FR 2154739A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7234605A
Other versions
FR2154739B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712149070 external-priority patent/DE2149070C3/de
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of FR2154739A1 publication Critical patent/FR2154739A1/fr
Application granted granted Critical
Publication of FR2154739B1 publication Critical patent/FR2154739B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
FR7234605A 1971-10-01 1972-09-29 Expired FR2154739B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19712149070 DE2149070C3 (de) 1971-10-01 1971-10-01 Phenoxyalkylcarbonsäurederivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel
DE2230383A DE2230383C3 (de) 1971-10-01 1972-06-22 Phenoxyalkylcarbonsäurederivate und Verfahren zur Herstellung derselben

Publications (2)

Publication Number Publication Date
FR2154739A1 true FR2154739A1 (fr) 1973-05-11
FR2154739B1 FR2154739B1 (fr) 1975-10-31

Family

ID=25761810

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7234605A Expired FR2154739B1 (fr) 1971-10-01 1972-09-29

Country Status (18)

Country Link
US (1) US3781328A (fr)
JP (1) JPS5112618B2 (fr)
AR (1) AR193131A1 (fr)
AT (1) AT319209B (fr)
BE (1) BE857160Q (fr)
CA (1) CA1010892A (fr)
CH (1) CH576427A5 (fr)
DE (1) DE2230383C3 (fr)
ES (1) ES407208A1 (fr)
FI (1) FI55493C (fr)
FR (1) FR2154739B1 (fr)
GB (1) GB1359264A (fr)
HK (1) HK41877A (fr)
HU (1) HU164572B (fr)
KE (1) KE2755A (fr)
NL (1) NL146793B (fr)
SE (1) SE393800B (fr)
YU (1) YU36291B (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2296407A1 (fr) * 1975-01-03 1976-07-30 Hoechst Ag Derives d'acide benzoique, leur procede de preparation et leur application
FR2318627A1 (fr) * 1975-07-19 1977-02-18 Boehringer Mannheim Gmbh Derives de l'acide phenylacetique et leur procede de preparation
FR2425427A1 (fr) * 1978-05-12 1979-12-07 Boehringer Mannheim Gmbh Procede pour la preparation de l'acide a-(4-(4-chlorobenzoylamino-ethyl)phenoxy)isobutyrique
FR2480279A1 (fr) * 1980-04-10 1981-10-16 Kaken Chemical Co Derives d'acides benzaminoethylphenoxycyclohexylacetiques, leur procede de preparation et leur application en therapeutique
EP0582441A1 (fr) * 1992-08-02 1994-02-09 Chemagis Ltd. Procédés pour la préparation de dérivés de tyramine
FR2898892A1 (fr) * 2006-03-24 2007-09-28 Genfit Sa Derives de n-(phenethyl)benzamide substitues,preparation et utilisations
FR2898894A1 (fr) * 2006-03-24 2007-09-28 Genfit Sa Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864366A (en) * 1971-12-29 1975-02-04 Eastman Kodak Co Novel acylamidophenol photographic couplers
GB1484413A (en) * 1974-04-18 1977-09-01 Kissei Pharmaceutical Aromatic amidocarboxylic acid derivatives
AT341512B (de) * 1975-01-09 1978-02-10 Thomae Gmbh Dr K Verfahren zur herstellung von neuen biphenylathern
US4042711A (en) * 1975-01-09 1977-08-16 Boehringer Ingelheim Gmbh Derivatives of biphenyloxy-lower alkanoic acids, salts thereof and their use as antihyperlipidemics
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
DE2541342A1 (de) * 1975-09-17 1977-03-31 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeuren und verfahren zur herstellung derselben
DE2546996C2 (de) * 1975-10-21 1984-07-05 Boehringer Mannheim Gmbh, 6800 Mannheim Phenoxyalkylcarbonsäure-Derivate, Verfahren zur Herstellung derselben sowie Arzneimittel, die diese Verbindungen als Wirkstoff enthalten
US4214094A (en) * 1977-03-30 1980-07-22 Fujisawa Pharmaceutical Co., Ltd. Substituted-phenyl substituted-alkyl ethers and the preparation thereof
US4281190A (en) * 1980-08-14 1981-07-28 Morton-Norwich Products, Inc. Process for preparing N-[2-(p-hydroxyphenyl)-ethyl]-p-chlorobenzamide
JPS57140754A (en) * 1981-02-24 1982-08-31 Kureha Chem Ind Co Ltd Dihydroxybenzoic acid derivative and physiologically active preparation containing the same
ATE116284T1 (de) * 1987-08-12 1995-01-15 Sanofi Sa Verfahren zur o-alkylierung von n- (hydroxy)aralkylphenylethanolamin.
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
EP1340508A1 (fr) 1998-12-23 2003-09-03 G.D. Searle LLC. Combinaisons d'inhibiteurs de la protéine de transfert du cholestéryle-ester et de dérivés de l'acide nicotinique utilisées dand le cadre de troubles cardio-vasculaires
ES2207330T3 (es) * 1998-12-23 2004-05-16 G.D. Searle Llc Combinaciones de un inhibidor de ibat y de un inhibidor de mtp para indicaciones cardiovasculares.
CA2356422C (fr) * 1998-12-23 2008-09-16 G.D. Searle Llc Combinaisons d'inhibiteurs de transport de l'acide biliaire ileal et d'inhibiteurs de la proteine de transfert de l'ester de cholesteryle utilisees dans le cadre de maladies cardio-vasculaires
DE69908645T2 (de) 1998-12-23 2004-05-13 G.D. Searle Llc, Chicago Kombinationen von cholesteryl ester transfer protein inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen
CA2356240C (fr) 1998-12-23 2008-04-01 G.D. Searle Llc Combinaisons d'inhibiteurs de la proteine de transfert de l'ester de cholesteryle et d'agents sequestrants de l'acide biliaire, utilisees dans le cadre de toubles cardio-vasculaires
WO2000038722A1 (fr) 1998-12-23 2000-07-06 G.D. Searle & Co. COMBINAISONS D'INHIBITEURS DE LA PROTEINE DE TRANSFERT DE L'ESTER DE CHOLESTERYLE ET D'INHIBITEURS DE LA HMG CoA-REDUCTASE UTILISEES DANS LE CADRE DE TROUBLES CARDIO-VASCULAIRES
MXPA01006472A (es) 1998-12-23 2004-03-10 Searle Llc Combinaciones de inhibidores de transporte de acido biliar ileal y derivados de acido fibrico para indicaciones cardiovasculares.
CZ20012345A3 (cs) * 1998-12-23 2001-12-12 G. D. Searle Llc Corporate Patent Department Kombinace inhibitorů transportu kyčelní ľlučové kyseliny a činidel pro sekvenci ľlučové kyseliny pro kardiovaskulární indikace
US7151191B2 (en) * 2000-01-13 2006-12-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
WO2001068096A2 (fr) * 2000-03-10 2001-09-20 Pharmacia Corporation Polytherapie pour la prophylaxie et le traitement d'etats et de troubles hyperlipidemiques
US6794544B2 (en) 2000-03-10 2004-09-21 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
AU2002240050A1 (en) * 2001-01-26 2002-08-06 Schering Corporation Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
EP1413331B1 (fr) * 2001-01-26 2007-10-03 Schering Corporation Combinaisons de l'activateur du récepteur du peroxisome (PPAR) fenofibrate avec l'inhibiteur d'absorption de stérol ezetimibe pour des indications vasculaires
EP1353694B1 (fr) * 2001-01-26 2007-12-19 Schering Corporation Combinaisons du ezetimibe et de l'aspirine pour le traitement des troubles vasculaires
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
DE60221798T2 (de) * 2001-01-26 2008-06-05 Schering Corp. Kombinationen von gallensäure sequestriermitteln und hemmern der sterol absorption zur behandlung von kardiovaskulären indikationen
IL156585A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
EP1911462A3 (fr) 2001-01-26 2011-11-30 Schering Corporation Combinaisons comprenant un inhibiteur d'absorption de stérol
ATE331512T1 (de) * 2001-01-26 2006-07-15 Schering Corp Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie
AU2002308778A1 (en) * 2001-05-25 2002-12-09 Schering Corporation Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
US20040077625A1 (en) * 2001-07-25 2004-04-22 Tremont Samuel J. Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake
ATE345793T1 (de) * 2001-09-21 2006-12-15 Schering Corp Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
WO2003026644A1 (fr) * 2001-09-21 2003-04-03 Schering Corporation Methodes de traitement ou de prevention d'une inflammation vasculaire au moyen d'un ou d'inhibiteurs d'absorption de sterol
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
MXPA04003524A (es) * 2001-11-02 2004-07-23 Searle Llc Compuestos de benzotiepina monofluorados y difluorados novedosos como inhibidores de transporte de acido biliar co-dependiente de sodio apical (asbt) y captacion de taurocolato.
MXPA04006255A (es) 2002-01-17 2004-09-27 Pharmacia Corp Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
CA2504916A1 (fr) * 2002-11-06 2004-05-27 Schering Corporation Inhibiteurs d'absorption de cholesterol pour le traitement de troubles auto-immuns
US7192944B2 (en) * 2003-03-07 2007-03-20 Schering Corp. Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
ATE418551T1 (de) 2003-03-07 2009-01-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP1601668B1 (fr) * 2003-03-07 2008-08-27 Schering Corporation Composes d'azetidinone substitues, leurs formulations et utilisations en vue du traitement de l'hypercholesterolemie
AP2501A (en) 2003-05-30 2012-10-22 Ranbaxy Lab Ltd Substituted pyrrole derivatives
WO2004108126A1 (fr) * 2003-06-06 2004-12-16 Snowden Pharmaceuticals, Llc Derives d'acide fibrique convenant au traitement du syndrome colon irritable
US20050096307A1 (en) * 2003-11-05 2005-05-05 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
JP2009514851A (ja) 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
TW200831497A (en) * 2006-10-12 2008-08-01 Epix Delaware Inc Carboxamide compounds and their use
TW200901959A (en) 2007-03-09 2009-01-16 Indigene Pharmaceuticals Inc Combination of metformin R-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
WO2009076404A1 (fr) * 2007-12-10 2009-06-18 Epix Delaware, Inc. Composés de carboxyamide et leur utilisation comme antagonistes du récepteur ccr2de la chimiokine
US8569282B2 (en) 2007-12-11 2013-10-29 Cytopathfinder, Inc. Carboxamide compounds and their use
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
WO2016127019A2 (fr) 2015-02-06 2016-08-11 Intercept Pharmaceuticals, Inc. Compositions pharmaceutiques pour thérapie combinée
US11278528B2 (en) 2017-11-15 2022-03-22 Nippon Chemiphar Co., Ltd. Activator of peroxisome proliferator-activated receptor
CN114144185A (zh) 2019-05-30 2022-03-04 英特塞普特医药品公司 用于治疗胆汁淤积性肝病的包含fxr激动剂和贝特类的药物组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1080503A (en) * 1965-07-02 1967-08-23 Smith & Nephew Substituted acetic acids and a process for their preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1080503A (en) * 1965-07-02 1967-08-23 Smith & Nephew Substituted acetic acids and a process for their preparation

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2296407A1 (fr) * 1975-01-03 1976-07-30 Hoechst Ag Derives d'acide benzoique, leur procede de preparation et leur application
FR2318627A1 (fr) * 1975-07-19 1977-02-18 Boehringer Mannheim Gmbh Derives de l'acide phenylacetique et leur procede de preparation
FR2425427A1 (fr) * 1978-05-12 1979-12-07 Boehringer Mannheim Gmbh Procede pour la preparation de l'acide a-(4-(4-chlorobenzoylamino-ethyl)phenoxy)isobutyrique
FR2480279A1 (fr) * 1980-04-10 1981-10-16 Kaken Chemical Co Derives d'acides benzaminoethylphenoxycyclohexylacetiques, leur procede de preparation et leur application en therapeutique
EP0582441A1 (fr) * 1992-08-02 1994-02-09 Chemagis Ltd. Procédés pour la préparation de dérivés de tyramine
FR2898892A1 (fr) * 2006-03-24 2007-09-28 Genfit Sa Derives de n-(phenethyl)benzamide substitues,preparation et utilisations
FR2898894A1 (fr) * 2006-03-24 2007-09-28 Genfit Sa Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
WO2007118964A1 (fr) * 2006-03-24 2007-10-25 Genfit Derives de n-(phenethyl)benzamide substitues, preparation et utilisations
WO2007118963A2 (fr) * 2006-03-24 2007-10-25 Genfit Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
WO2007118963A3 (fr) * 2006-03-24 2007-12-21 Genfit Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations

Also Published As

Publication number Publication date
NL146793B (nl) 1975-08-15
JPS4840741A (fr) 1973-06-15
HU164572B (fr) 1974-03-28
GB1359264A (en) 1974-07-10
DE2230383C3 (de) 1981-12-03
FR2154739B1 (fr) 1975-10-31
NL7212931A (fr) 1973-04-03
US3781328A (en) 1973-12-25
JPS5112618B2 (fr) 1976-04-21
YU245572A (en) 1980-10-31
FI55493C (fi) 1979-08-10
BE857160Q (fr) 1978-01-26
CA1010892A (en) 1977-05-24
CH576427A5 (fr) 1976-06-15
ES407208A1 (es) 1975-11-01
YU36291B (en) 1982-06-18
SE393800B (sv) 1977-05-23
AU4723372A (en) 1973-08-23
AT319209B (de) 1974-12-10
AR193131A1 (es) 1973-03-30
DE2230383A1 (de) 1974-01-17
KE2755A (en) 1977-10-14
FI55493B (fi) 1979-04-30
DE2230383B2 (de) 1980-10-09
HK41877A (en) 1977-08-19

Similar Documents

Publication Publication Date Title
FR2154739B1 (fr)
ATA136472A (fr)
AR196074A1 (fr)
AU2564071A (fr)
AU2742671A (fr)
AU2894671A (fr)
AU2941471A (fr)
AU2952271A (fr)
AU3005371A (fr)
AU1109576A (fr)
AU3038671A (fr)
AU2907471A (fr)
AU2577671A (fr)
AR202997Q (fr)
AU2740271A (fr)
AU2755871A (fr)
AU2836771A (fr)
AU2837671A (fr)
AU2854371A (fr)
AR199640Q (fr)
AU2938071A (fr)
AU3025871A (fr)
AU2875571A (fr)
AU2927871A (fr)
AU2399971A (fr)

Legal Events

Date Code Title Description
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0216, 920519

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0214, 720929

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0216, 720929

CL Concession to grant licences